Intelligent Bio Solutions to Acquire Bio-Gen Ltd. for $1.5M
Ticker: INBS · Form: 8-K · Filed: Jan 6, 2025 · CIK: 1725430
Sentiment: neutral
Topics: acquisition, biotechnology, merger
TL;DR
Intelligent Bio Solutions is buying Bio-Gen Ltd. for $1.5M to boost its product line. Deal expected Q1 2025.
AI Summary
Intelligent Bio Solutions Inc. announced on January 2, 2025, that it has entered into a definitive agreement to acquire all of the outstanding equity interests of Bio-Gen Ltd. for a purchase price of $1.5 million. The acquisition is expected to close in the first quarter of 2025, subject to customary closing conditions. This strategic move aims to expand Intelligent Bio Solutions' product portfolio and market reach.
Why It Matters
This acquisition could significantly expand Intelligent Bio Solutions' market presence and product offerings in the biotechnology sector, potentially leading to increased revenue and market share.
Risk Assessment
Risk Level: medium — Acquisitions carry inherent risks, including integration challenges, potential overpayment, and failure to achieve expected synergies, which could impact the company's financial performance.
Key Numbers
- $1.5M — Acquisition Price (Intelligent Bio Solutions Inc. is acquiring Bio-Gen Ltd. for this amount.)
Key Players & Entities
- Intelligent Bio Solutions Inc. (company) — Acquiring company
- Bio-Gen Ltd. (company) — Acquired company
- $1.5 million (dollar_amount) — Purchase price for Bio-Gen Ltd.
- January 2, 2025 (date) — Date of definitive agreement
- first quarter of 2025 (date) — Expected closing period for the acquisition
FAQ
What is the primary strategic rationale behind Intelligent Bio Solutions Inc.'s acquisition of Bio-Gen Ltd.?
The acquisition is intended to expand Intelligent Bio Solutions' product portfolio and market reach.
What is the total purchase price for Bio-Gen Ltd.?
The purchase price for all of the outstanding equity interests of Bio-Gen Ltd. is $1.5 million.
When is the acquisition of Bio-Gen Ltd. expected to be completed?
The acquisition is expected to close in the first quarter of 2025.
Are there any conditions that must be met for the acquisition to close?
Yes, the acquisition is subject to customary closing conditions.
What was the previous name of Intelligent Bio Solutions Inc.?
The company was formerly known as GBS Inc. and Glucose Biosensor Systems (Greater China) Holdings, Inc.
Filing Stats: 450 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2025-01-06 17:15:17
Key Financial Figures
- $0.01 — nge on which registered Common Stock, $0.01 par value INBS The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 33KB
- 0001493152-25-001055.txt ( ) — 203KB
- inbs-20250102.xsd (EX-101.SCH) — 3KB
- inbs-20250102_lab.xml (EX-101.LAB) — 33KB
- inbs-20250102_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: January 6, 2025 INTELLIGENT BIO SOLUTIONS INC. By: /s/ Spiro Sakiris Name: Spiro Sakiris Title: Chief Financial Officer